Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis
European Respiratory Journal · 2026
DOI: 10.1183/13993003.02796-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Shunlian Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Bronchiectasis, Nitric Oxide, Kartagener Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Major Project, Guangzhou National Laboratory, Shanghai Municipal Education Commission.
Abstract (Originalsprache)
Rationale
Primary ciliary dyskinesia (PCD), an underdiagnosed genetic disorder characterised by dysfunctional cilia, is a known cause of bronchiectasis.
Objectives
To prospectively identify PCD among patients with bronchiectasis using nasal nitric oxide (nNO) and clinical features, and to characterise genetic features.
Methods
This cross-sectional study enrolled adolescent and adult patients with bronchiectasis from the BE-China registry at Shanghai Pulmonary Hospital. Individuals with either strong clinical suspicion or nNO ≤77 nL·min −1 received a structured diagnostic work-up, including transmission electron microscopy and whole-exome sequencing. Diagnoses followed the 2025 European Respiratory Society/American Thoracic Society PCD diagnostic guidelines.
Results
Among 373 patients with bronchiectasis, 27 (7.4%) were in the PCD group (14 “confirmed PCD” and 13 “PCD highly likely”). nNO showed high screening accuracy (sensitivity 84.8%, specificity 97.1%). Patients with PCD were younger and had earlier bronchiectasis onset. Age-adjusted regression analysis showed independent associations between PCD and lower body mass index (regression coefficient (RC) −1.5, 95% CI −2.9 to −0.1), forced expiratory volume in 1 s (FEV 1 ) % predicted (RC −18.4, 95% CI −28.3 to −8.6), forced vital capacity (FVC) % predicted (RC −11.3, 95% CI −19.5 to −3.0), and FEV 1 /FVC (RC −10.3, 95% CI −16.9 to −3.8). Strong associations were observed with rhinosinusitis (OR 25.3, 95% CI 8.8 to 92.1) and Pseudomonas aeruginosa infection (OR 8.5, 95% CI 3.2 to 25.7). Situs inversus occurred in 25.9% of patients with PCD. DNAH11 was the most common pathogenic gene.
Conclusions
Patients with PCD had more severe disease, reinforcing the need for structured screening in patients with bronchiectasis. nNO combined with clinical features is an effective and reliable screening strategy for PCD in bronchiectasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China.
- Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
- Shunlian Hu, Xiyue Shen and Jiayi Wang contributed equally to this work.
- Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
- Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center of Lung Research (DZL), Hannover, Germany.
ORCID-Profile: Felix C Ringshausen, Amelia Shoemark, Jin-Fu Xu
Förderung
- National Science and Technology Major Project
- Guangzhou National Laboratory
- Shanghai Municipal Education Commission
- National Natural Science Foundation of China
Zitieren
APA
Hu, S., Shen, X., Wang, J., Lu, H., Liu, Y., Gu, S., Ge, A., Yang, J., Mao, B., Ringshausen, F. C., Shoemark, A., & Xu, J. F. (2026). Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis. European Respiratory Journal. https://doi.org/10.1183/13993003.02796-2025
Vancouver
Hu S, Shen X, Wang J, Lu H, Liu Y, Gu S, et al. Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis. European Respiratory Journal. 2026. doi:10.1183/13993003.02796-2025
BibTeX
@article{Hu2026,
author = {Hu, Shunlian and Shen, Xiyue and Wang, Jiayi and Lu, Haiwen and Liu, Yang and Gu, Shuyi and Ge, Ai and Yang, Jiawei and Mao, Bei and Ringshausen, Felix C and Shoemark, Amelia and Xu, Jin-Fu},
title = {Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.02796-2025}
}
EUVIMED